Re: Immunotherapy - not all approaches work the same

Thanks Marion, much excitement surrounding Immunotherapy and let's hope that much of it will be carried through to CC.

Hugs,

Gavin

Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.

Re: Immunotherapy - not all approaches work the same

Just wondering...What are the hospitals/who are the physicians and immunogists leading the exploration of immunotherapy for cholangiocarcinoma? What are the opportunities for the inclusion of cholangio if FDA approval is received for treatment of a different cancer?

Re: Immunotherapy - not all approaches work the same

Judy..... Most major centers are involved in these studies. You might want to start with the treating physician, as he/she may be able to lead you to a center closest for participation. I believe that once approved for a different cancer, physicians will then use the "off label" and the pd-1 and anti pd-L1 pembrolizumab (lambrolizumab) drug are under investigation and are expected to be released by the end of this year.

The information expressed is not medical advice. The discussion boards are not intended to replace the services of a trained health professional or to be a substitute for the medical advice of physicians or other healthcare providers. Read the full disclaimer.